Protalix BioTherapeutics (PLX) Amortization of Deferred Charges (2013 - 2023)
Protalix BioTherapeutics' quarterly Amortization of Deferred Charges came in at $59000.0 in Q4 2023, down 22.37% year-on-year from $76000.0 in Q4 2022, and down 1.67% quarter-over-quarter from $60000.0 in Q3 2023.
Protalix BioTherapeutics has reported Amortization of Deferred Charges for 11 years, with the latest figure at $59000.0 in Q4 2023.
- For the quarter ending Q4 2023, Amortization of Deferred Charges fell 22.37% year-over-year to $59000.0; the trailing twelve-month figure through Dec 2023 stood at $267000.0 (down 11.0% YoY), and the FY2023 full-year result was $267000.0, down 11.0% from the prior year.
- Amortization of Deferred Charges for Q4 2023 stood at $59000.0, down from $60000.0 in the prior quarter.
- The five-year high for Amortization of Deferred Charges was $983000.0 in Q2 2021, with the low at $59000.0 in Q4 2023.
- Average Amortization of Deferred Charges over 5 years is $485050.0, with a median of $672500.0 recorded in 2019.
- Year-over-year, Amortization of Deferred Charges gained 16.48% in 2020 and slumped 92.78% in 2022.
- Tracing PLX's Amortization of Deferred Charges over 5 years: stood at $794000.0 in 2019, then grew by 16.12% to $922000.0 in 2020, then slumped by 88.72% to $104000.0 in 2021, then fell by 26.92% to $76000.0 in 2022, then slipped by 22.37% to $59000.0 in 2023.
- The last three Amortization of Deferred Charges figures came in at $59000.0 (Q4 2023), $60000.0 (Q3 2023), and $68000.0 (Q2 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Protalix BioTherapeutics | 164.49 Mn | 153.70 Mn | 29.62 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 59,000.00 |
| Dec 31, 2023 | 59,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Sep 30, 2023 | 60,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Jun 30, 2023 | 68,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Mar 31, 2023 | 80,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Dec 31, 2022 | 76,000.00 |
| Sep 30, 2022 | 78,000.00 |
| Sep 30, 2022 | 78,000.00 |
| Jun 30, 2022 | 71,000.00 |
| Jun 30, 2022 | 71,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Mar 31, 2022 | 75,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Dec 31, 2021 | 104,000.00 |
| Sep 30, 2021 | 641,000.00 |
| Sep 30, 2021 | 641,000.00 |
| Jun 30, 2021 | 983,000.00 |
| Jun 30, 2021 | 983,000.00 |
| Mar 31, 2021 | 945,000.00 |
| Mar 31, 2021 | 945,000.00 |
| Dec 31, 2020 | 922,000.00 |
| Dec 31, 2020 | 922,000.00 |
| Sep 30, 2020 | 883,000.00 |
| Sep 30, 2020 | 883,000.00 |
| Jun 30, 2020 | 845,000.00 |
| Jun 30, 2020 | 845,000.00 |
| Mar 31, 2020 | 820,000.00 |
| Mar 31, 2020 | 820,000.00 |
| Dec 31, 2019 | 794,000.00 |
| Dec 31, 2019 | 794,000.00 |
| Sep 30, 2019 | 762,000.00 |
| Sep 30, 2019 | 762,000.00 |
| Jun 30, 2019 | 731,000.00 |
| Jun 30, 2019 | 731,000.00 |
| Mar 31, 2019 | 704,000.00 |
| Mar 31, 2019 | 704,000.00 |
| Dec 31, 2018 | 686,000.00 |
| Dec 31, 2018 | 686,000.00 |
| Sep 30, 2018 | 659,000.00 |
| Sep 30, 2018 | 659,000.00 |
| Jun 30, 2018 | 638,000.00 |
| Jun 30, 2018 | 638,000.00 |
| Mar 31, 2018 | 619,000.00 |
| Mar 31, 2018 | 619,000.00 |
| Dec 31, 2017 | 624,000.00 |
| Dec 31, 2017 | 624,000.00 |
| Sep 30, 2017 | 569,000.00 |
| Sep 30, 2017 | 569,000.00 |
| Jun 30, 2017 | 551,000.00 |
| Jun 30, 2017 | 551,000.00 |
| Mar 31, 2017 | 590,000.00 |
| Mar 31, 2017 | 590,000.00 |
| Dec 31, 2016 | 235,000.00 |
| Dec 31, 2016 | 235,000.00 |
| Sep 30, 2016 | 112,000.00 |
| Sep 30, 2016 | 112,000.00 |
| Jun 30, 2016 | 111,000.00 |
| Jun 30, 2016 | 111,000.00 |
| Mar 31, 2016 | 110,000.00 |
| Mar 31, 2016 | 110,000.00 |
| Dec 31, 2015 | 112,000.00 |
| Dec 31, 2015 | 112,000.00 |
| Sep 30, 2015 | 112,000.00 |
| Sep 30, 2015 | 112,000.00 |
| Jun 30, 2015 | 111,000.00 |
| Jun 30, 2015 | 111,000.00 |
| Mar 31, 2015 | 110,000.00 |
| Mar 31, 2015 | 110,000.00 |
| Mar 31, 2014 | 109,000.00 |
| Mar 31, 2014 | 109,000.00 |
| Dec 31, 2013 | 112,000.00 |
| Dec 31, 2013 | 112,000.00 |